The Steering Committee of IBD Campus direct the overall scope and content of this website. They also participate actively in developing all course materials for this website, as well as reviewing all contributions for scientific accuracy and clinical content.

The members of the Steering Committee are as follows:


Professor Ailsa Hart
Consultant Gastroenterologist
St Mark’s Hospital

Ailsa Hart trained in medicine at Oxford University and was awarded a First Class Honours Degree in 1992. She achieved Membership of the Royal College of Physicians in 1998 and trained in Gastroenterology and General Internal Medicine in London. She also worked at the Academic Medical Centre in Amsterdam in 2004. She achieved her PhD in 2005 with Imperial College, London funded by a Wellcome Trust Fellowship. She became a Fellow of the Royal College of Physicians in 2013. Professor Hart was appointed to the consultant staff of St Mark’s Hospital in 2008 and became a Clinical Senior Lecturer at Imperial College London, having been awarded a highly competitive Clinical Senior Lectureship by the Higher Education Funding Council for England. She is currently Director of St Mark’s Hospital Inflammatory Bowel Disease Unit, which has around 5000 patients, and Honorary Senior Clinical Lecturer at Imperial College.

Professor Hart’s clinical work covers the spectrum of gastrointestinal diseases, with a particular interest in inflammatory bowel diseases. Her research interests focus on intestinal immunology and bacteriology aiming to further our understanding of the pathogenesis of inflammatory intestinal disorders. She is involved in teaching and training both nationally and internationally and has lectured by invitation at over 200 meetings. She has also published over 100 papers and book chapters. She is a member of national and international IBD committees and consensus groups.

Professor Hart is one of five members of the Clinical Committee of the European Crohn’s and Colitis Organisation (ECCO); on the IBD Committee for the British Society of Gastroenterology, UK Patient and Public Involvement Lead for Gastroenterology for the CRN; Sub-Dean of St Mark’s Hospital; and collaborates widely across the UK particularly within the UK IBD Genetics Consortium. She was elected onto the International Organisation for the study of IBD (IOIBD) in 2014. The IOIBD’s mission statement is “to promote the health of people with IBD worldwide by setting the direction for patient care, education and research.” This is a highly prestigious appointment, as only 50 physicians and surgeons worldwide have been elected onto this organisation.

Lectures /Advisory Boards: AbbVie, Atlantic, BMS, Ferring, Hospira, MSD, Napp, Pfizer, Takeda, Warner Chilcott

Dr Gareth Parkes
Consultant Gastroenterologist
Barts Health NHS Trust
Gareth Parkes trained at Cambridge and Barts and the Royal London Medical School before commencing specialist training in North East Thames. He has a PhD from King’s College London on the role of the microbiota in irritable bowel syndrome (IBS) and has published on GI microbiota in IBS, inflammatory bowel disease (IBD), as well as probiotics and Clostridium difficile. Dr Parkes now works as part of the IBD team at the Royal London Hospital with on-going research interests in commercial clinical trials and the mucosa-associated microbiome and GI disease.

Receipt of grants/research supports: Takeda
Receipt of honoraria or consultation fees: Abbvie, Allergan, Ferring, Napp, Takeda

Dr Tim Raine
Consultant Gastroenterologist,
Cambridge University Hospitals NHS Foundation Trust,
Tim Raine is a clinical lecturer in gastroenterology at the University of Cambridge and an honorary faculty at the Wellcome Trust Sanger Institute, Hinxton. His clinical subspecialty interest is in inflammatory bowel disease (IBD). His research, funded by the Wellcome Trust, is focused on understanding the regulation of the gastrointestinal immune system, in particular the immunological basis for genetic risk in IBD. Dr Raine has an active interest in human clinical trials in IBD and serves on the British Society of Gastroenterology IBD Clinical Research Group. He has worked with a number of pharmaceutical companies on pre-clinical and clinical trials in IBD therapeutics, including first-in-human studies.

Receipt of honoraria or consultation fees: Abbvie, Astellas, Dr Falk, GSK, Hospira, MSD, Takeda

Dr Arthur Dunk
Consultant Physician
Eastbourne DGH
East Sussex Healthcare NHS Trust
Arthur Dunk attended Medical School in Glasgow and qualified MB ChB with commendation in 1978.
After General Medical training in Glasgow, and after gaining MRCP(UK), he moved to London to work in the world renowned Liver Unit at the Royal Free Hospital. During his time at the Royal Free Dr Dunk gained wide experience in the care and management of patients with all forms of acute and chronic liver disorders. Dr Dunk then moved back to Scotland and worked in the Gastrointestinal Unit attached to the Aberdeen Teaching Hospitals. Under the supervision of Professors Peter Brunt and Ashley Mowat, and Dr Tom Sinclair, further experience was gained in luminal Gastroenterology, and especially so in inflammatory bowel disorders. In 1989 Dr Dunk gained accreditation in Internal Medicine and Gastroenterology from the Joint Committee on Higher Medical Training. In late 1989 Dr Dunk moved to his consultant post in Eastbourne, and he was the town’s first Gastroenterologist. Over 20 years later he is working in an environment that can provide first class care in almost all aspects of modern day Gastroenterology and Hepatology. Dr Dunk has served on many local, regional, and national committees since his consultant appointment. During this time he has been Trust Endoscopy Lead, Clinical Director of Medicine, member of the upper GI cancer group of the Sussex Cancer Network, and member of the Sussex Hepatology Network. He has also served twice on the Liver Section committee of the British Society of Gastroenterology and is currently on the council of the Royal College of Physicians and Surgeons of Glasgow. Dr Dunk examines both in the UK and overseas for the medical Royal Colleges.

No relationships to disclose